Skip to main content

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Ultragenyx Pharmaceutical Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
311
+11 vs. Q1 2025
Shares held
94.1M
+4.32M (+4.8%) vs. Q1 2025
Total value
$3.42B
+$169.1M (+5.2%) vs. Q1 2025
New holders
54
117 more added
Sold out
43
108 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 311 institutions
Q1 2021: 255 institutionsQ2 2021: 242 institutionsQ3 2021: 223 institutionsQ4 2021: 235 institutionsQ1 2022: 240 institutionsQ2 2022: 225 institutionsQ3 2022: 233 institutionsQ4 2022: 228 institutionsQ1 2023: 230 institutionsQ2 2023: 243 institutionsQ3 2023: 221 institutionsQ4 2023: 237 institutionsQ1 2024: 270 institutionsQ2 2024: 275 institutionsQ3 2024: 302 institutionsQ4 2024: 314 institutionsQ1 2025: 301 institutionsQ2 2025: 311 institutionsQ3 2025: 303 institutionsQ4 2025: 288 institutionsQ1 2026: 298 institutionsQ2 2026: 311 institutions
Value heldQ2 2025: $3.42B
Q1 2021: $7.73BQ2 2021: $6.24BQ3 2021: $6.01BQ4 2021: $5.69BQ1 2022: $4.87BQ2 2022: $4.03BQ3 2022: $2.81BQ4 2022: $3.15BQ1 2023: $2.76BQ2 2023: $3.21BQ3 2023: $2.52BQ4 2023: $3.84BQ1 2024: $3.73BQ2 2024: $3.63BQ3 2024: $4.83BQ4 2024: $3.68BQ1 2025: $3.25BQ2 2025: $3.42BQ3 2025: $2.87BQ4 2025: $2.16BQ1 2026: $2.05BQ2 2026: $3.55B
Institutions holding RARE and their total value by quarter
QuarterHoldersValue
Q2 2026311$3.55B
Q1 2026298$2.05B
Q4 2025288$2.16B
Q3 2025303$2.87B
Q2 2025311$3.42B
Q1 2025301$3.25B
Q4 2024314$3.68B
Q3 2024302$4.83B
Q2 2024275$3.63B
Q1 2024270$3.73B
Q4 2023237$3.84B
Q3 2023221$2.52B
Q2 2023243$3.21B
Q1 2023230$2.76B
Q4 2022228$3.15B
Q3 2022233$2.81B
Q2 2022225$4.03B
Q1 2022240$4.87B
Q4 2021235$5.69B
Q3 2021223$6.01B
Q2 2021242$6.24B
Q1 2021255$7.73B

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q1 2025.

Institutions holding RARE in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc10,213,422$371.4M0.01%+217,196+2.2%Added
BlackRock, Inc.6,256,145$227.5M0.00%+97,879+1.6%Added
Sands Capital Management, LLC3,943,485$143.4M0.41%−220,076−5.3%Reduced
JPMorgan Chase & Co3,260,868$118.6M0.01%+2,951,397+953.7%Added
Price T Rowe Associates Inc2,886,268$104.9M0.01%−332,674−10.3%Reduced
Baker Bros. Advisors LP2,772,692$100.8M0.98%+1,196,578+75.9%Added
FMR LLC2,604,588$94.7M0.01%+2,223,166+582.9%Added
State Street Corp2,572,240$93.5M0.00%−46,250−1.8%Reduced
Suvretta Capital Management, LLC2,278,000$82.8M3.12%+253,500+12.5%Added
Clearbridge Investments, LLC2,140,577$77.8M0.06%−119,128−5.3%Reduced
Federated Hermes, Inc.2,049,501$74.5M0.14%−5,699−0.3%Reduced
Wellington Management Group LLP1,871,820$68.1M0.01%−577,678−23.6%Reduced
Geode Capital Management, LLC1,712,931$62.3M0.00%+66,394+4.0%Added
RTW Investments, LP1,707,402$62.1M0.88%00.0%Unchanged
Pictet Asset Management Holding SA1,699,944$61.9M0.06%+290,745+20.6%Added
Alkeon Capital Management LLC1,685,729$61.3M0.30%00.0%Unchanged
Deutsche Bank AG1,665,852$60.6M0.02%−35,641−2.1%Reduced
Adage Capital Partners GP, L.L.C.1,529,474$55.6M0.09%−619,526−28.8%Reduced
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1,452,130$52.8M0.13%+301,674+26.2%Added
Alyeska Investment Group, L.P.1,429,437$52.0M0.18%−65,914−4.4%Reduced
Rock Springs Capital Management LP1,391,072$50.6M3.15%−3,362−0.2%Reduced
Deep Track Capital, LP1,350,000$49.1M1.58%00.0%Unchanged
Alliancebernstein L.P.1,255,203$45.6M0.01%+7,823+0.6%Added
Assenagon Asset Management S.A.1,163,755$42.3M0.07%+947,865+439.0%Added
Frazier Life Sciences Management, L.P.983,715$35.8M1.43%+325,000+49.3%Added
Norges Bank983,638$35.8M0.00%00.0%Unchanged
Farallon Capital Management, L.L.C.898,000$32.7M0.15%+898,000New
Two Sigma Advisers, LP860,400$31.3M0.06%−76,800−8.2%Reduced
Invesco Ltd.724,115$26.3M0.00%−489,167−40.3%Reduced
Morgan Stanley638,879$23.2M0.00%+12,479+2.0%Added
Bank of America Corp637,690$23.2M0.00%+109,710+20.8%Added
Eagle Health Investments LP627,600$22.8M5.63%00.0%Unchanged
Charles Schwab Investment Management Inc615,969$22.4M0.00%+22,848+3.9%Added
Driehaus Capital Management LLC606,407$22.0M0.18%−246,250−28.9%Reduced
Two Sigma Investments, LP576,901$21.0M0.04%−56,251−8.9%Reduced
Schonfeld Strategic Advisors LLC567,175$20.6M0.16%−257,243−31.2%Reduced
Polar Capital Holdings Plc551,383$20.0M0.11%−100,000−15.4%Reduced
Loomis Sayles & Co L P549,538$20.0M0.03%−11,941−2.1%Reduced
First Light Asset Management, LLC547,905$19.9M2.58%−84,128−13.3%Reduced
D. E. Shaw & Co., Inc.540,801$19.7M0.02%−15,616−2.8%Reduced
Candriam Luxembourg S.C.A.526,267$19.1M0.11%−201,750−27.7%Reduced
Frontier Capital Management Co LLC525,464$19.1M0.18%+525,464New
Point72 Asset Management, L.P.515,968$18.8M0.04%−460,084−47.1%Reduced
Nuveen, LLC505,152$18.4M0.01%−13,391−2.6%Reduced
Standard Life Aberdeen plc501,056$18.2M0.03%+22,152+4.6%Added
Northern Trust Corp493,470$17.9M0.00%−74,919−13.2%Reduced
Massachusetts Financial Services Co486,632$17.7M0.01%−15,391−3.1%Reduced
Millennium Management LLC486,341$17.7M0.02%−226,052−31.7%Reduced
GW&K Investment Management, LLC481,288$17.5M0.16%−20,923−4.2%Reduced
Franklin Resources Inc475,156$17.3M0.00%−125,290−20.9%Reduced
Bank of New York Mellon Corp473,887$17.2M0.00%−222,274−31.9%Reduced
Emerald Advisers, LLC461,402$16.8M0.61%−54,826−10.6%Reduced
AXA S.A.456,666$16.6M0.05%+371+0.1%Added
UBS Group AG440,432$16.0M0.00%−29,050−6.2%Reduced
Fred Alger Management, LLC430,339$15.6M0.07%−94,298−18.0%Reduced
Goldman Sachs Group Inc425,994$15.5M0.00%−54,275−11.3%Reduced
Victory Capital Management Inc415,733$15.1M0.01%+405,303+3,885.9%Added
MPM Oncology Impact Management LP395,700$14.4M2.49%−2,745−0.7%Reduced
Manufacturers Life Insurance Company, The390,389$14.2M0.01%+97,015+33.1%Added
Schroder Investment Management Group336,173$12.2M0.01%+71,888+27.2%Added
Avoro Capital Advisors LLC330,000$12.0M0.21%−500,000−60.2%Reduced
Legal & General Group Plc313,804$11.4M0.00%+54,837+21.2%Added
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main311,101$11.3M0.01%00.0%Unchanged
Jacobs Levy Equity Management, Inc303,565$11.0M0.04%+303,565New
UBS Asset Management Americas Inc300,962$10.9M0.00%+68,602+29.5%Added
Emerald Mutual Fund Advisers Trust295,317$10.7M0.65%−45,658−13.4%Reduced
Moore Capital Management, LP290,000$10.5M0.21%+50,000+20.8%Added
Motley Fool Wealth Management, LLC275,082$10.0M0.60%+125,486+83.9%Added
Woodline Partners LP273,251$9.94M0.05%+4,789+1.8%Added
Perceptive Advisors LLC270,000$9.82M0.37%+270,000New
Hudson Bay Capital Management LP258,681$9.41M0.06%−121,519−32.0%Reduced
Blue Owl Capital Holdings LP255,238$9.28M3.00%+102,000+66.6%Added
Privium Fund Management B.V.253,304$9.18M1.98%+3,500+1.4%Added
AQR Capital Management LLC252,333$9.17M0.01%+160,286+174.1%Added
Bank of Nova Scotia241,985$8.80M0.02%+241,985New
Caption Management, LLC237,500$8.64M0.79%+58,672+32.8%Added
Macquarie Group Ltd235,097$8.55M0.01%−48,452−17.1%Reduced
Trexquant Investment LP234,912$8.54M0.10%−33,754−12.6%Reduced
BNP Paribas Arbitrage, SA225,826$8.21M0.01%+48,975+27.7%Added
Catalio Capital Management, LP213,402$7.76M1.63%+213,402New
WCM Investment Management, LLC210,469$7.69M0.02%+8,256+4.1%Added
Renaissance Technologies LLC208,300$7.57M0.01%−91,300−30.5%Reduced
Peregrine Capital Management LLC189,520$6.89M0.21%+20,053+11.8%Added
Fisher Asset Management, LLC185,756$6.75M0.00%−21,999−10.6%Reduced
Man Group plc184,177$6.70M0.01%−270,971−59.5%Reduced
Barclays PLC178,611$6.49M0.00%+35,730+25.0%Added
Motley Fool Asset Management LLC167,448$6.09M0.28%+82,975+98.2%Added
Swiss National Bank161,052$5.86M0.00%00.0%Unchanged
PDT Partners, LLC156,693$5.70M0.32%+51,772+49.3%Added
Avidity Partners Management LP154,000$5.60M1.12%−168,100−52.2%Reduced
Parkman Healthcare Partners LLC147,980$5.38M0.62%−156,264−51.4%Reduced
EFG Asset Management (North America) Corp.135,850$4.94M0.70%+12,908+10.5%Added
Superstring Capital Management LP130,422$4.74M5.91%+130,422New
TD Asset Management Inc123,884$4.50M0.00%−14,600−10.5%Reduced
Gilder Gagnon Howe & Co LLC123,127$4.48M0.05%+106,239+629.1%Added
Russell Investments Group, Ltd.120,195$4.37M0.01%+16,373+15.8%Added
Algert Global LLC116,347$4.23M0.09%−13,973−10.7%Reduced
Pinnacle Associates Ltd114,268$4.15M0.06%−29,107−20.3%Reduced
California Public Employees Retirement System112,509$4.09M0.00%−27,937−19.9%Reduced
Jane Street Group, LLC111,726$4.06M0.01%−53,921−32.6%Reduced